0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Images in Neurology |

Rhinocerebral Mucormycosis in a 12-Year-Old Girl

Muhammad Ibrahim, MD; Shubhangi Chitnis, MD; Kenneth Fallon, MD; Thomas Roberts, MD
Arch Neurol. 2009;66(2):272-273. doi:10.1001/archneurol.2008.546.
Text Size: A A A
Published online

Extract

A 12-year-old girl was seen for a 3-day history of diplopia, right-sided otalgia, and right-sided face numbness that had progressed during the past 24 hours to blindness and proptosis in the right eye. The medications she had been taking included azathioprine and prednisolone for autoimmune hepatitis, diagnosed 3 months earlier.

Physical examination showed right-sided facial numbness, ophthalmoplegia, a fixed dilated right pupil, and diminished visual acuity in her right eye. There was prominent right-sided facial droop with tongue deviation to the right. Preliminary laboratory workup showed that the patient was in diabetic ketoacidosis. Ear, nose, and throat examination showed nonviable-appearing tissue in the right nasal cavity. Magnetic resonance imaging of her head revealed nonviable tissue involving the right middle and inferior turbinates (Figure, E). The patient underwent an immediate nasal biopsy with debridement of the nasal mucosa. The debrided tissue was found to be dusky and nonviable and did not bleed during debridement. The tissue biopsy findings were consistent with a diagnosis of mucormycosis (Figure, A-D). She was given intravenous amphotericin B to which oral posaconazole and intrathecal amphotericin B were added during the next week. The initial follow-up magnetic resonance images showed progression of the disease with significant intracranial extension (Figure, F). She continued antifungal drug therapy and follow-up in the clinic; 6 months after diagnosis, she showed remission of the disease, without any new neurologic deficits, with magnetic resonance imaging showing regression in the size of abnormally enhanced areas seen previously.

Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
/>
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure.

Shown here are photomicrographs and magnetic resonance images of the lesion. A, Frozen section biopsy demonstrating occlusion of a vessel by ribbonlike, nonseptate hyphae (arrow). Note the surrounding mixed inflammatory response. B, Same slide under higher magnification showing vascular occlusion by nonseptate hyphae (arrow) branching at right angles. C, Biopsy showing invasive, nonseptate fungal hyphae (arrows) in a nerve fascicle. D, Periodic acid–Schiff stain distinguishing the elongated, pink fungal hyphae (arrow) from the lighter connective tissue background. E, Postgadolinium T1-weighted axial magnetic resonance image showing nonenhancing tissue (arrow) in the right nasal cavity compatible with necrotic mucosa. F, Similar technique showing abscesses appearing as ring-enhancing lesions in the right medial temporal lobe and right cerebellopontine angle. Also note occlusion of the right internal carotid artery (arrow) and thrombosis of the right cavernous sinus, although there was no radiographic evidence of cerebral infarction.

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();